Latest immunotherapy news
FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dupilumab Reduces Mucus Plug Scores With Moderate-to-Severe Asthma
posted November 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
COVID Vaccine Before ICI Initiation Tied to Increased Survival in Patients With Cancer
posted October 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Obesity Linked to Early-Onset Cancer Risk in Young Adults 
AI Tool Trained on Dermoscopy Images Helps ID Skin Cancer .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
